Wie hoch ist der Preis für Minerva Surgical, Inc. (UTRS)

Preis für Minerva Surgical, Inc. (UTRS) ist $0.0001

Wie hoch ist die Marktkapitalisierung für Minerva Surgical, Inc. (UTRS)

Marktkapitalisierung für Minerva Surgical, Inc. (UTRS) ist $888.00

Minerva Surgical, Inc. (UTRS) Ausstehende Aktien

Minerva Surgical, Inc. functions as a commercial-stage medical technology enterprise, specializing in the creation, production, and distribution of innovative, minimally invasive solutions tailored to address the uterine healthcare needs of women throughout the United States. Their suite of offerings features advanced endometrial ablation systems, including the Minerva ES and Genesys HTA. They also provide the Symphion Tissue Removal System, a sophisticated, minimally invasive device for uterine tissue removal that uniquely integrates bladeless tissue resection, coagulation capabilities, continuous visualization during procedures, and precise intrauterine pressure monitoring. Additionally, the Resectr Tissue Resection Device is a handheld surgical tool engineered for the hysteroscopic removal and diagnostic evaluation of endometrial polyps. These specialized instruments are utilized by obstetrician-gynecologists across a variety of clinical settings, such as hospitals, outpatient ambulatory surgical centers, and private physician practices. The company was founded in 2008 and is headquartered in Santa Clara, California.

Jahr	Ausstehende Aktien	ändert
Nicht genügend Daten für die angegebenen Daten.

Jahr

Ausstehende Aktien

ändert

Nicht genügend Daten für die angegebenen Daten.

Unternehmen	Ausstehende Aktien	Unterschied	Land
GE HealthCare Technologies Inc. GEHC.US	453.00M	-	US
Pro Medicus Limited PME.AX	104.48M	-	AU
BrightSpring Health Services, Inc. Common Stock BTSG.US	205.38M	-	US
Tempus AI, Inc. TEM.US	179.92M	-	US
Signify Health, Inc. SGFY.US	-	-	US

Unternehmen

Ausstehende Aktien

Unterschied

Land